Pharmacy

Your Article Summary

See Latest Articles

MORE-CARE Trial to Assess Remote Monitoring Impact on Heart Failure Patients and Healthcare Utilization
Medtronic, 06/23/09

More than 22 million people worldwide have heart failure, a chronic condition in which the heart is unable to adequately pump blood throughout the body. Today, Medtronic, Inc. announced the first worldwide enrollments in the MORE-CARE trial, which will compare two disease management strategies for heart failure patients treated with an implantable device for cardiac resynchronization therapy. MORE-CARE aims to demonstrate that remote monitoring of these patients via the Medtronic CareLink Network is superior to in-office visits alone, in terms of clinical effectiveness and healthcare system utilization.

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Recent Caffeine Ingestion Reduces Adenosine Efficacy in the Treatment of Paroxysmal Supraventricular Tachycardia
Academic Emergency Medicine, 12/11/09

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09

Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09

 See all of Cardiac/Hypertension

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09

Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/11/09

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors
Journal of Clinical Oncology, 12/10/09

 See all of Drug Trials